Mounjaro side effects: complete clinical guide

Reviewed by: Dr Abdullah

Last reviewed: August 2026 · Reading time: 6 minutes

Quick answer: The most common Mounjaro side effects are nausea, diarrhoea, vomiting, constipation and abdominal pain, each affecting more than 1 in 10 people. They are usually mild, concentrated in the first four weeks and after every dose increase, and they typically settle within days. Severe persistent abdominal pain, facial swelling or uncontrollable vomiting require immediate medical attention.

How often each reaction occurs

The reactions almost everyone notices

Gastrointestinal symptoms dominate. They are the direct consequence of how the medicine works: it slows stomach emptying, so food sits longer and appetite falls.

What matters clinically is not whether you feel sick, but whether you can keep fluids down. Nausea that makes you skip a meal is expected. Nausea that stops you drinking is a reason to call your prescriber.

Hypoglycaemia is very common in one group only: people also taking insulin or a sulfonylurea. If that is you, the dose of the existing medicine should be reduced before starting, not after symptoms appear.

The reactions that change clinical decisions

Gallstones are common and usually silent. Rapid weight loss alters how the gallbladder empties, and undissolved cholesterol can crystallise. Most cause no symptoms. Those that do present as sudden severe pain under the right ribs.

Acute pancreatitis is uncommon but is the reaction most likely to end treatment permanently. It presents as severe, unrelenting pain high in the abdomen, often radiating through to the back, usually with vomiting. It does not ease with position or ordinary painkillers.

Anaphylaxis and angioedema are rare. Swelling of the face, lips, tongue or throat with breathing or swallowing difficulty is an emergency.

When to seek help, and where

Call 112 immediately if you have:

• Swelling of the face, mouth or throat, or difficulty breathing or swallowing

• Severe abdominal pain that will not settle, particularly if it spreads to the back

• Collapse, confusion, or inability to stay upright

Do not wait to contact us first. These symptoms need emergency care.

Contact your Medetone prescriber the same day if:

• Vomiting or diarrhoea is stopping you keeping fluids down

• Symptoms are getting worse instead of settling

• Any symptom has lasted more than two weeks

• You have sudden pain under your right ribs

Interactions that change your risk

Most consumer guides omit this section. It is the part with real consequences.

Oral contraceptives. Delayed stomach emptying can reduce absorption of the combined pill. Use an additional barrier method, or a non-oral method, for four weeks after starting and for four weeks after every dose increase.

Insulin and sulfonylureas. Combining raises hypoglycaemia risk substantially and normally requires a dose reduction first.

Other oral medicines. Absorption of anything swallowed can change. Flag narrow-therapeutic-index medicines to your prescriber.

Other GLP-1 medicines. Never combine two. No added benefit, compounded risk.

Surgery and sedation. Delayed emptying raises the risk of stomach contents entering the lungs under anaesthesia. Tell every clinician involved, well in advance.

Who needs caution, and who should not start

Not suitable during pregnancy, when planning pregnancy, while breastfeeding, under 18 for weight management, or with known allergy to any component.

Closer monitoring required with a history of pancreatitis, severe gastroparesis, diabetic retinopathy or macular oedema, severe kidney or liver impairment, or previous gallbladder disease.

Eligibility is a clinical judgement made before supply. That is the same across every EU member state.

When Mounjaro side effects start and how long they last

Weeks 1 to 4. Peak intensity. Nausea and appetite change are sharpest here. After each dose increase. A smaller repeat, typically several days to two weeks. Beyond three months. Most people find symptoms have substantially settled at a stable dose.

Gallstones, injection site reactions and raised pancreatic enzymes do not follow this curve and can appear at any point.

There is no obligation to reach the highest dose. Staying at your current dose for longer, or permanently, is a legitimate clinical option if it works. Escalating faster than the schedule allows is not.

Reducing the impact

Most Mounjaro side effects can be softened, though rarely eliminated entirely.

Nausea: smaller portions, eaten slowly. Avoid fatty and fried food. Sip fluids frequently. Diarrhoea: oral rehydration rather than plain water. Reduce caffeine and alcohol. Constipation: fibre, fluid, daily movement. Discuss laxatives with a pharmacist first. Reflux: do not lie down within three hours of eating. Injection sites: rotate weekly, new needle each time, let skin dry before injecting.

Frequently asked questions

Do Mounjaro side effects mean the dose is wrong? 

Not usually. Reactions during dose escalation are expected and temporary. Reactions that worsen instead of settling, or last beyond a few weeks, do warrant a review.

Is there a thyroid cancer warning in Europe?

European authorised product information does not carry the rodent thyroid tumour warning found in some non-EU labelling. The finding came from a two-year rat study. Rodents are markedly more susceptible to these tumours than humans, and no causal link has been established in human trials.

Does hair thinning reverse?

It is generally linked to the pace of weight loss rather than to the medicine directly, and usually recovers once weight stabilises.

Can I drink alcohol?

There is no absolute prohibition, but alcohol worsens nausea, reflux and dehydration.

Are Mounjaro side effects worse than with other injections in this class?

Tolerability varies by individual, not reliably by product. The frequency bands above come from the authorised European product information for tirzepatide specifically.

Medical information. This article is for information only and does not replace diagnosis, prescription or medical advice. Tirzepatide is a prescription-only medicine throughout the EU. Always follow your prescriber's instructions and read the patient information leaflet supplied with your medicine.

References

• European Medicines Agency, Mounjaro EPAR product information: https://www.ema.europa.eu/en/medicines/human/EPAR/mounjaro

• AEMPS, Agencia Española de Medicamentos y Productos Sanitarios (Spain): https://www.aemps.gob.es

• CIMA, AEMPS medicines information centre (Spain): https://cima.aemps.es

• ANSM, Agence nationale de sécurité du médicament (France): https://ansm.sante.fr

• AIFA, Agenzia Italiana del Farmaco (Italy): https://www.aifa.gov.it

• Ministero della Salute (Italy): https://www.salute.gov.it

• BfArM, Bundesinstitut für Arzneimittel und Medizinprodukte (Germany): https://www.bfarm.de

• CBG-MEB, College ter Beoordeling van Geneesmiddelen (Netherlands): https://www.cbg-meb.nl

• Bijwerkingencentrum Lareb (Netherlands): https://www.lareb.nl

• European Commission, Union Register of Medicinal Products: https://ec.europa.eu/health/documents/community-register/html/reg_hum_act.htm